NeutriSci International Logo
CA64129Y1079
A12GAQ
NU.V

NeutriSci International

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last year, NeutriSci International had revenue of €314.48k and net profit of -€529.48k
(EUR) 2022
YoY
Revenue 314.48k 458.75%
Gross profit -29.82k 108.60%
Net profit -529.48k 51.60%
EBITDA -503.88k 52.54%

Fundamentals

Metric Value
Market capitalization
€582.46k
Number of shares
503.06m
52-week high/low
€0.00116 - €0.00116
Dividends No
Beta
-0.83
P/E ratio
-1.09
PEG ratio
-0.02
P/B ratio
-1.35
P/S ratio
1.95

Company profile

NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada, the United States, Europe, Asia, and South America. It offers neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Name
NeutriSci International
CEO
Glen Rehman
Headquarters Vancouver, bc
Canada
Website
Sector
Health Care
Industry
Pharmaceuticals
IPO
07/09/2016

Ticker symbols

Exchange Symbol
Tsxv
NU.V
Pnk
NRXCF
Frankfurt
1N9.F
München
1N9.MU
🍪

Parqet  uses cookies. Learn more